Standard BioTools Inc (LAB)
1.92
+0.02
(+1.05%)
USD |
NASDAQ |
Sep 27, 16:00
1.92
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash from Financing (TTM): -50.26M for June 30, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -50.26M |
March 31, 2024 | -23.98M |
December 31, 2023 | -6.809M |
September 30, 2023 | -6.076M |
June 30, 2023 | -4.917M |
March 31, 2023 | 210.12M |
December 31, 2022 | 230.76M |
September 30, 2022 | 238.32M |
June 30, 2022 | 248.15M |
March 31, 2022 | 35.06M |
December 31, 2021 | 15.96M |
September 30, 2021 | 9.094M |
June 30, 2021 | 19.69M |
March 31, 2021 | 20.33M |
December 31, 2020 | 20.86M |
September 30, 2020 | 22.21M |
June 30, 2020 | 1.611M |
March 31, 2020 | 2.14M |
December 31, 2019 | 2.79M |
September 30, 2019 | 60.96M |
June 30, 2019 | 61.00M |
March 31, 2019 | 57.86M |
December 31, 2018 | 57.66M |
September 30, 2018 | -2.111M |
June 30, 2018 | 26.89M |
Date | Value |
---|---|
March 31, 2018 | 28.94M |
December 31, 2017 | 29.00M |
September 30, 2017 | 28.80M |
June 30, 2017 | -0.064M |
March 31, 2017 | 0.114M |
December 31, 2016 | 0.116M |
September 30, 2016 | 0.195M |
June 30, 2016 | 0.346M |
March 31, 2016 | 1.613M |
December 31, 2015 | 5.34M |
September 30, 2015 | 6.302M |
June 30, 2015 | 6.785M |
March 31, 2015 | 6.559M |
December 31, 2014 | 200.33M |
September 30, 2014 | 201.60M |
June 30, 2014 | 202.06M |
March 31, 2014 | 201.54M |
December 31, 2013 | 5.806M |
September 30, 2013 | 2.069M |
June 30, 2013 | 55.11M |
March 31, 2013 | 53.33M |
December 31, 2012 | 48.52M |
September 30, 2012 | 48.89M |
June 30, 2012 | -6.037M |
March 31, 2012 | -6.111M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-50.26M
Minimum
Jun 2024
248.15M
Maximum
Jun 2022
52.30M
Average
17.82M
Median
Cash from Financing (TTM) Benchmarks
Ainos Inc | 12.52M |
Zomedica Corp | -- |
LENSAR Inc | -0.06M |
Intelligent Bio Solutions Inc | -- |
Adagio Medical Holdings Inc | -1.934M |